CN104788345B - A kind of production method of high-purity hydrochloric acid metformin - Google Patents
A kind of production method of high-purity hydrochloric acid metformin Download PDFInfo
- Publication number
- CN104788345B CN104788345B CN201510197742.2A CN201510197742A CN104788345B CN 104788345 B CN104788345 B CN 104788345B CN 201510197742 A CN201510197742 A CN 201510197742A CN 104788345 B CN104788345 B CN 104788345B
- Authority
- CN
- China
- Prior art keywords
- temperature
- vacuum
- synthesis reactor
- dicyandiamide
- product
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C277/00—Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C277/08—Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups of substituted guanidines
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
The invention discloses the production method of a kind of high-purity hydrochloric acid metformin, with N methyl pyrrolidone as solvent, dicyandiamide and dimethylamine hydrochloride are solute, add synthesis reactor reaction, through stirring, cool down, dry, wash, crystallize, drying steps, prepare metformin hydrochloride.Using preparation method of the present invention to prepare metformin hydrochloride, yield is more than 96.4%, and product purity can be more than 99.93%.
Description
Technical field
The invention belongs to pharmaceutical chemicals synthesis technical field, concretely relate to a kind of high-purity, high yield, low one-tenth
Originally, the production method of environmentally friendly metformin hydrochloride.
Background technology
Metformin hydrochloride is the blood sugar lowering for the treatment of non-insulin-dependent diabetes mellitus, has raising type Ⅱdiabetes mellitus and suffers from
The glucose tolerance of person, reduces the effect of basis and post-prandial glycemia.It is characterized in not promoting the secretion of insulin, but promotion group
Knit the picked-up to glucose, to normal person's blood glucose without obvious blood sugar reducing function, the most do not cause hypoglycemia, compare safety.At glycosuria
During sick preventing and treating, the utilization of metformin hydrochloride is more and more extensive, becomes irreplaceable oral antidiabetic drug.Insulin supports
Anti-(insulin resistence, IR) is one of independent hazard factor of cardiovascular disease, and it is sent out with essential hypertension
Raw, development, prognosis and treatment have substantial connection, and the intervention to IR becomes one of focus treating hypertension.Metformin hydrochloride
Can improve IR hypertension animal and the IR of hyperpietic and make blood pressure drops, prompting medicine improves IR hypertension animal and primary
After the IR of property hyperpietic, Synergistic Hypotensive Effects can be produced.
The synthesis dominant response of metformin hydrochloride is that dicyandiamide carries out addition, dicyandiamide and diformazan with dimethylamine hydrochloride
Amine hydrochlorate reaction condition is different from process for refining, and the gap such as the product yield that obtains, purity, crystal formation, impurity content is bigger.Salt
It is following several that acid metformin has the production method of industrial applications prospect to have:
1, solvent method is in the presence of an organic, and dicyandiamide and dimethylamine hydrochloride are in different temperatures, differential responses time
Under the conditions of carry out additive reaction, crude product is through being refining to obtain medical certified products.Solvent is used mainly to have following several types.
(1) alcohols, such as isoamyl alcohol；N-amyl alcohol；Hexalin；Ethylene glycol；Glycerol；
(2) amide-type such as N,N-dimethylformamide；DMAC N,N' dimethyl acetamide；
(3) dimethyl sulfoxide；
(4) benzene-like compounds, such as toluene, dimethylbenzene；
(5) ethers, such as glycol monoethyl ether；Propylene glycol monomethyl ether；
No matter using which kind of solvent in prior art, reaction temperature is generally 130～160 DEG C, the response time be generally 6～
12h or longer, crude product refining needs to adjust pH value through persalt, and the multiple working procedure such as activated carbon decolorizing, ethyl alcohol recrystallization, although obtaining
Product this index of its impurity content sometimes can meet the requirements, but the product yield that industrialized production obtains is on the low side, has
Be only about 85%, directly affects the economic benefit of product.Sometimes primary purification accepted product percentage only has about 80%, does not conforms to
Lattice product need secondary refining to can be only achieved quality index requirement but the economic benefit of product is greatly affected.
2, fusion method is at relatively high temperatures, and after reaction raw materials dicyandiamide and dimethylamine hydrochloride are molten into liquid, a step is anti-
Metformin hydrochloride should be generated.This synthetic method craft principle is simple, with short production cycle, but still has following deficiency: (1) reacts not
Completely, reaction early stage raw material is solid-state, and reaction later stage finished product is solid-state, the only homogeneous reaction of short-term, and reaction homogeneity is poor, becomes
In product, the raw material proportion for reaction is big, brings difficulty to follow-up refining；(2) feed stock conversion is low, and product yield is low, product
Of poor benefits；(3) there is potential safety hazard in production.Dicyandiamide and dimethylamine salt fusion temperature are more than 160 DEG C, and two kinds of materials are higher than molten
During point, response speed is fast, substantially moment reaction, temperature rapid increase in the short time, it may occur that slug etc.；(4) to equipment material
Matter requires harshness, and equipment investment is excessive, and production operation is wayward.
The purity that prior art production metformin hydrochloride exists is low, yield is low, cycle length, cost high, produce existence pacifies
The deficiencies such as full hidden danger, pollution environment, in the production of metformin hydrochloride, it is crucial that dicyandiamide and dimethylamine hydrochloride
Additive reaction, the research both at home and abroad such as prepared by raw material dimethylamine hydrochloride, finished product is dried, application reached its maturity, its researching value
Additive reaction not as dicyandiamide Yu dimethylamine hydrochloride.In recent years, metformin hydrochloride had been used as preparation treatment parkinson
Medicine aspect research has breakthrough, and its purity and impurity content are proposed tightened up requirement；Metformin hydrochloride
In terms of synthesis other medicines, there has also been new development, prepare metformin hydrochloride content height, dicyandiamide, dimethylamine, four paracyanogen
The product that the impurity contents such as amine are low is the focus problem paid close attention to, study the most of the same trade.
Summary of the invention:
For solving above-mentioned technical problem, the present invention provides a kind of high-purity hydrochloric acid metformin preparation method, it is achieved following
Goal of the invention:
1, the product purity of preparation is more than 99.93%；
2, improving dicyandiamide and dimethylamine hydrochloride conversion ratio, improve metformin hydrochloride yield, product yield is more than
96.4%；
3, reduce the additive reaction temperature of dicyandiamide and dimethylamine hydrochloride, reduce the generation of side reaction, reduce in product
Impurity content；
4, simplify metformin hydrochloride crude product refining process, shorten the product purification cycle；
5, single device efficiency is improved；
6, reduce the material ratio of dicyandiamide and dimethylamine hydrochloride, reduce production cost, improve product benefit；
7, environmentally safe.
To achieve the above object of the invention, the present invention adopts the following technical scheme that
A kind of production method of high-purity hydrochloric acid metformin, including solvent and solute being added synthesis reactor, stirring, cold
But, wash, crystallize, drying steps.
The following is and the further of technique scheme is improved:
Described solvent and solute being added synthesis reactor step, solvent is N-Methyl pyrrolidone, and solute is dicyandiamide and two
Methylamine hydrochloride.
Described dicyandiamide, dimethylamine hydrochloride, N-Methyl pyrrolidone weight ratio be: 1:0.975～1.025:1.8～
4.5。
In described washing step, amount of alcohol added is 3-5.5 times of dicyandiamide weight.
Described whipping step includes secondary temperature elevation step, and described secondary temperature elevation step, synthesis reactor temperature rise is to 62-65 DEG C.
Described whipping step also includes regulating vacuum step for the first time, described first regulation vacuum step, regulation
In synthesis reactor, vacuum is 0.03-0.045MPa.
Described whipping step also includes three heating steps, and three times described heating steps are by synthesis reactor temperature rise to 75-
79℃。
Described whipping step also includes Secondary Control vacuum step, described Secondary Control vacuum step, regulation
In synthesis reactor, vacuum is 0.06MPa.
Described whipping step also includes secondary stirring step, described secondary stirring step, regulates speed of agitator 80-
100 revs/min, stirring reaction 60-90 minute；
In described crystallisation step, lowering the temperature for the first time, crystallization kettle temperature drop is to 40-50 DEG C；Reducing temperature twice, by still temperature drop to 0-
10℃。
Use metformin hydrochloride purity prepared by described method more than 99.93%.
The present invention compared with prior art, has the advantages that
1, product purity is more than 99.93%.When synthesis reactor temperature 62-65 DEG C to response system evacuation, remove solvent
In, micro-moisture in raw material and in reaction system, effectively prevent dicyandiamide when higher than 80 DEG C (normal pressure), decompose generation NH3Enter
And generate NH4Cl residual affects product quality in the product.
Reduce the additive reaction temperature of dicyandiamide and dimethylamine hydrochloride, reduce and cause dicyandiamide poly because temperature is the highest
The side reactions such as the generation of body, ammonium chloride generation, reduce impurity content.
Additive reaction is complete, and by setting different mixing speed, different falling temperature gradient, the different cooling time of staying etc. arrange
Executing, the metformin hydrochloride crystal grain making precipitation is uniform, and crystal formation is uniform, and crystallization process is easily controllable, is used for doing piece agent pressure
During sheet, tablet hardness is high.
2, product yield is more than 96.4%.With N-Methyl pyrrolidone as solvent, use coarse vacuum, lower pair of cyanogen of cryogenic conditions
Amine and the additive reaction of dimethylamine hydrochloride, response speed is fast, and the response time is short, and side reaction and amount of by-products reduce, and raw material turns
Rate improves.
Finished product all uses and is dried under vacuum condition, and rate of drying is fast, and solvent is removed thoroughly, and dust reclaims and uses, and improves
Product yield and economic benefit.
3, single device efficiency improves.Dicyandiamide improves with dimethylamine hydrochloride conversion ratio, improves metformin hydrochloride
Yield, improves single device efficiency.
4, the production cycle shortens.The centrifugal metformin hydrochloride crude product thrown away is centrifugal, so after using 80-95% washing with alcohol
After dry at reduced pressure conditions, prepare the satisfactory product of clarity, eliminate existing technique dilute hydrochloric acid and regulate pH value, use
The operations such as activated carbon decolorizing, decrease the loss of finished product.Simplify metformin hydrochloride crude product refining process, shorten product purification week
Phase.
5, mother solution can be recycled for multiple times, and does not affect the quality of the product of preparation.It is centrifuged after throwing away metformin hydrochloride
Mother solution can be recycled for multiple times, suitably supplement fresh solvent, product matter depending on Recycling Mother Solution number of times and additive reaction situation
Measure unaffected.Reduce the material ratio of dicyandiamide and dimethylamine hydrochloride, reduce production cost, improve product benefit.
Additive reaction is complete, lower the temperature, the centrifugal Recycling Mother Solution obtained uses；Crude product simply uses ethanol and refines, second
After alcohol is refined, the centrifugal solvent obtained entered simple distillation, ethanol reuse, and the N-Methyl pyrrolidone containing product returns to addition
Course of reaction is continuing with.
6, producing temperature to decline, reaction temperature reduces 25-55 DEG C than atmospheric operation.It is molten for using N-Methyl pyrrolidone
Agent, disposably adds raw material dicyandiamide and dimethylamine hydrochloride in reactor in coarse vacuum, and stirring, gradient increased temperature, material is molten
Under the conditions of coarse vacuum, setting different temperatures and different mixing speed, carry out additive reaction after solution, react gentle, do not have punching
The situations such as material, vigorous reaction.
7, environmentally safe.The centrifugal liquid obtained after washing with alcohol metformin hydrochloride crude product is centrifugal, steams through simple
Evaporating, obtaining ethanol can be continuing with；Bottom material is mainly dissolved with the N-of the materials such as minimal amount of unreacting material, a small amount of product
Methyl pyrrolidone solvent, can be returned directly in additive reaction use, system three-waste free discharge, it is achieved that keep the safety in production, clean
Produce.
Detailed description of the invention:
Embodiment 1
1, solvent and solute are added synthesis reactor
Synthesis reactor used is 1000L glass-lined kettle.By vacuum by solvent N-methyl pyrilidone 600Kg suction synthesis reactor,
Open stirring, add solute dicyandiamide 250Kg and dimethylamine hydrochloride 250Kg.
2, stirring
(1) stir for the first time
Open steam valve, open vapour and heat up, regulate speed of agitator 50-60 rev/min with converter.
(2) secondary temperature elevation
Stir 15-20 minute by synthesis reactor temperature rise to 62 DEG C.
(3) vacuum is regulated for the first time
Opening vacuum pump, in regulation synthesis reactor, vacuum is 0.04MPa, after vacustat, continues stirring 10-20 and divides
Clock.
Heat up for (4) three times
Open big steam valve, continue to heat up, stir 15-20 minute by synthesis reactor temperature rise to 75 DEG C.
(5) Secondary Control vacuum
In regulation synthesis reactor, vacuum is 0.06MPa.
(6) secondary stirring
After vacustat, regulate speed of agitator 80 revs/min, continue stirring reaction 80 minutes.
3, cooling
(1) cool down for the first time
Being passed through temperature to synthesis reactor chuck is 30 DEG C of cooling water, and speed of agitator keeps 80 revs/min, by still temperature in 90 minutes
It is down to 60 DEG C.
(2) cooling twice
Then regulation speed of agitator is 65 revs/min, is passed through chilled brine to synthesis reactor chuck, and 210 minutes by still temperature drop extremely
20℃。
(3) three coolings
Regulation speed of agitator is 35 revs/min, keeps being passed through chilled brine to synthesis reactor chuck, and 60 minutes by still temperature drop to 5
℃.Obtain mixture A.
3, dry
From synthesis reactor, mixture A is put into centrifuge dry, flow out to centrifuge discharging tube no liquid.Prepare hydrochloride
Biguanide crude product.Mother solution continues reuse.
4, washing
(1) metformin hydrochloride crude product is added
It is 80-90%(mass ratio by concentration) ethanol 1000kg, with vacuum suction washing kettle, opens stirring, adds from centrifugal
The metformin hydrochloride crude product that machine takes off.
(2) heat up
Opening steam valve, open vapour and heat up, temperature 55～70 DEG C keep 60～90 minutes.Obtain mixture B.
5, crystallization
(1) filter
By compressed air, mixture B in washing kettle is entered crystallization kettle after filter.
(2) lower the temperature for the first time
To crystallization kettle chuck be first passed through temperature cycles cooling water, by still temperature drop to 45 DEG C in 60-100 minute, keep 20～
30 minutes.
(3) reducing temperature twice
Then being passed through chilled brine to synthesis reactor chuck, 270-300 minute by still temperature drop to 5 DEG C.
(4) centrifuge dripping
Centrifuge dripping, prepares metformin hydrochloride crystal.
(5) mother solution reuse
The centrifugal mother solution obtained returns to addition through simple distillation, ethanol reuse, the N-Methyl pyrrolidone containing product
Course of reaction is continuing with.
6, it is dried
Metformin hydrochloride crystal vacuum be 0.078MPa, temperature be 75 DEG C under the conditions of be dried 120 minutes, produced
Product.Product purity 99.96%, dicyandiamide content 0.002%.Product yield is 96.7%.
After testing: other technical performance index of the product such as table 1 prepared:
The portion of techniques performance indications of table 1 embodiment 1 product
Embodiment 2
Using the preparation process of embodiment 1, solvent for use is in embodiment 1 drying step, puts into centrifuge from synthesis reactor
Dry the mother solution produced, continue reuse, prepare metformin hydrochloride.
Embodiment 3
Using the preparation process of embodiment 1, solvent for use is in embodiment 2 drying step, puts into centrifuge from synthesis reactor
Dry the mother solution produced, continue reuse, prepare metformin hydrochloride.
Embodiment 4
Solvent and solute are added synthesis reactor step, and solvent for use is in embodiment 3 drying step, from synthesis reactor put into from
Scheming dries the mother solution produced, and continues reuse, adds N-Methyl pyrrolidone 100Kg suction synthesis reactor.Side according to embodiment 1
Method prepares metformin hydrochloride.
Embodiment 1-4, the product purity of preparation and product yield, such as table 2.
Table 2 embodiment 1-4 product purity and yield
As seen from Table 2, being centrifuged the mother solution after throwing away metformin hydrochloride can be recycled for multiple times, depending on Recycling Mother Solution time
Number and additive reaction situation suitably supplement fresh solvent, and the product quality of preparation is unaffected.
Embodiment 5
Using the preparation process of embodiment 1, changing section technological parameter, be shown in Table 3, test, result of the test is shown in Table 4.
Table 3 embodiment 5-8 technological parameter situation
Embodiment 5-8, the purity of the product of preparation and yield, such as table 4
The purity of product prepared by table 4 embodiment 5-8 and yield
Finally it is noted that the foregoing is only the preferred embodiments of the present invention, it is not limited to the present invention,
Although being described in detail the present invention with reference to previous embodiment, for a person skilled in the art, it still may be used
So that the technical scheme described in foregoing embodiments is modified, all within the spirit and principles in the present invention, made appoint
What amendment, equivalent, improvement etc., should be included within the scope of the present invention.
Claims (3)
1. the production method of a high-purity hydrochloric acid metformin, it is characterised in that: include solvent and solute are added synthesis reactor,
Stir, cool down, wash, crystallize, drying steps；
Described solvent is N-Methyl pyrrolidone；Solute is dicyandiamide and dimethylamine hydrochloride；Described dicyandiamide, dimethylamine salt
Hydrochlorate, N-Methyl pyrrolidone weight ratio be: 1:0.975～1.025:1.8～4.5；Described whipping step includes secondary liter
Temperature step, described secondary temperature elevation step, synthesis reactor temperature rise is to 62-65 DEG C；Described whipping step also includes regulating vacuum for the first time
Degree step, described first regulation vacuum step, in regulation synthesis reactor, vacuum is 0.03-0.045MPa；
In described washing step, amount of alcohol added is 3-5.5 times of dicyandiamide weight；
Described whipping step also includes Secondary Control vacuum step, described Secondary Control vacuum step, regulation synthesis
In still, vacuum is 0.06MPa；
Described whipping step also includes secondary stirring step, described secondary stirring step, regulation speed of agitator 80-100 turns/
Point, stirring reaction 60-90 minute；
Described whipping step also includes three heating steps, three times described heating steps by synthesis reactor temperature rise to 75-79 DEG C.
The production method of a kind of high-purity hydrochloric acid metformin the most according to claim 1, it is characterised in that: described knot
In brilliant step, lowering the temperature for the first time, crystallization kettle temperature drop is to 40-50 DEG C；Reducing temperature twice, by still temperature drop to 0-10 DEG C.
The production method of a kind of high-purity hydrochloric acid metformin the most according to claim 1, it is characterised in that: use described
Metformin hydrochloride purity prepared by method is more than 99.93%.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610666893.2A CN106278953B (en) | 2015-04-24 | 2015-04-24 | A kind of production method for improving Metformin hydrochloride purity |
| CN201510197742.2A CN104788345B (en) | 2015-04-24 | 2015-04-24 | A kind of production method of high-purity hydrochloric acid metformin |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510197742.2A CN104788345B (en) | 2015-04-24 | 2015-04-24 | A kind of production method of high-purity hydrochloric acid metformin |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610666893.2A Division CN106278953B (en) | 2015-04-24 | 2015-04-24 | A kind of production method for improving Metformin hydrochloride purity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104788345A CN104788345A (en) | 2015-07-22 |
| CN104788345B true CN104788345B (en) | 2016-10-05 |
Family
ID=53553587
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510197742.2A Expired - Fee Related CN104788345B (en) | 2015-04-24 | 2015-04-24 | A kind of production method of high-purity hydrochloric acid metformin |
| CN201610666893.2A Expired - Fee Related CN106278953B (en) | 2015-04-24 | 2015-04-24 | A kind of production method for improving Metformin hydrochloride purity |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610666893.2A Expired - Fee Related CN106278953B (en) | 2015-04-24 | 2015-04-24 | A kind of production method for improving Metformin hydrochloride purity |
Country Status (1)
| Country | Link |
|---|---|
| CN (2) | CN104788345B (en) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105481726A (en) * | 2015-12-17 | 2016-04-13 | 石家庄市普力制药有限公司 | Preparation method of metformin hydrochloride |
| CN107445869A (en) * | 2017-07-18 | 2017-12-08 | 山东科源制药股份有限公司 | A kind of synthetic method of Metformin hydrochloride |
| CN110194727A (en) * | 2018-12-05 | 2019-09-03 | 武汉武药制药有限公司 | A kind of refining methd of Metformin hydrochloride |
| CN111909058A (en) * | 2019-05-07 | 2020-11-10 | 石家庄市普力制药有限公司 | Production method for producing metformin hydrochloride |
| CN110256300B (en) * | 2019-06-26 | 2022-04-05 | 武汉大学 | Metformin hydrochloride compound and metformin hydrochloride tablet composition |
| CN112028795A (en) * | 2020-09-17 | 2020-12-04 | 重庆医药高等专科学校 | Synthesis method of metformin hydrochloride |
| CN113248409B (en) * | 2021-05-21 | 2023-01-03 | 海南海力制药有限公司 | Synthetic method and application of metformin hydrochloride |
| CN113292460A (en) * | 2021-06-18 | 2021-08-24 | 天津应天成科技有限公司 | Preparation method of metformin hydrochloride |
| CN113735741A (en) * | 2021-09-13 | 2021-12-03 | 天方药业有限公司 | Synthetic preparation method of metformin hydrochloride |
| CN114130348A (en) * | 2022-02-07 | 2022-03-04 | 天津凯莱英医药科技发展有限公司 | Continuous synthesis system and continuous synthesis method for metformin hydrochloride |
| CN115108945B (en) * | 2022-07-14 | 2024-05-17 | 山东省分析测试中心 | Preparation method of metformin hydrochloride crystal and monodisperse rod-shaped crystal with uniform granularity obtained by adopting method |
| CN115974726A (en) * | 2022-10-28 | 2023-04-18 | 东北师范大学 | Method for separating metformin hydrochloride crude product |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101450918B (en) * | 2007-11-30 | 2011-08-10 | 山东方兴科技开发有限公司 | Metformin hydrochloride purification method |
| CN102516130A (en) * | 2011-11-26 | 2012-06-27 | 赤峰万泽制药有限责任公司 | Preparation method of metformin hydrochloride |
| CN104119250A (en) * | 2014-07-15 | 2014-10-29 | 徐晓宁 | Production method of high-purity metformin hydrochloride |
-
2015
- 2015-04-24 CN CN201510197742.2A patent/CN104788345B/en not_active Expired - Fee Related
- 2015-04-24 CN CN201610666893.2A patent/CN106278953B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN104788345A (en) | 2015-07-22 |
| CN106278953B (en) | 2017-09-29 |
| CN106278953A (en) | 2017-01-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104788345B (en) | A kind of production method of high-purity hydrochloric acid metformin | |
| CN104829495B (en) | A kind of method that two-component solvent prepares high-purity high-yield Metformin hydrochloride | |
| CN104119250A (en) | Production method of high-purity metformin hydrochloride | |
| CN105061289B (en) | A kind of method for preparing pharmaceutical grade L tryptophans | |
| CN109422642B (en) | Refining method of benzoic acid, production method and equipment of pharmaceutical grade sodium benzoate | |
| KR101899015B1 (en) | Process for the production of l-carnitine tartrate | |
| CN111909058A (en) | Production method for producing metformin hydrochloride | |
| CN107445869A (en) | A kind of synthetic method of Metformin hydrochloride | |
| CN104355990B (en) | Method for recycling and mechanically using L- (+) -tartaric acid in D-ethyl ester production | |
| CN104961724B (en) | A kind of vanguard technology for obtaining high-purity Desloratadine | |
| CN111170880A (en) | Production system and method of acetaminophen | |
| CN103570522B (en) | A kind of production method of 99.5% sodium formiate | |
| CN106916068B (en) | A kind of simple and convenient benzalkonium chloride production method | |
| CN101811991B (en) | Method for preparing L-arginine nitrate | |
| CN102746238A (en) | Preparation method of pyrimethanil | |
| CN104726528B (en) | The technique that a kind of method through prepares ampicillin | |
| CN106336352A (en) | Synthesis method of 6-fluorosalicylic acid | |
| CN102850242A (en) | Preparation method of guanidine propionic acid nitrate | |
| CN104151299B (en) | Compound, crystal-form compound and preparation method thereof | |
| CN1219788C (en) | Dynamic controlled crystalline method of preparing erythromycin from erythromysin salt | |
| CN115477594A (en) | Continuous preparation method of L-canacyanol | |
| CN115710218B (en) | Crystallization method for improving flunixin meglumine fluidity | |
| WO2024119477A1 (en) | Preparation method for psicose crystal | |
| CN101817758B (en) | Preparation method of L-valine nitrate | |
| CN105481771A (en) | Preparation process of ozagrel intermediate methyl (E)-4-(imidazolylmethyl) cinnamate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| EXSB | Decision made by sipo to initiate substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C41 | Transfer of patent application or patent right or utility model | ||
| CB03 | Change of inventor or designer information |
Inventor after: Zhang Gongxiao Inventor after: Li Qingzhi Inventor after: Guo Yankai Inventor after: Li Qiang Inventor after: Meng Xianfeng Inventor after: Ren Jingyi Inventor after: Yang Ronghua Inventor after: Chen Hongyu Inventor after: Guo Xueyang Inventor after: Yang Minghui Inventor after: Zhang Xiuling Inventor after: Lv Junfeng Inventor before: Li Qingzhi Inventor before: Guo Yankai Inventor before: Li Qiang |
|
| COR | Change of bibliographic data | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20160810 Address after: 271016 the Great Wall Road, Shandong, Tai'an, No. 619 Applicant after: Taishan Hospital Address before: 255299 Shandong Province, Zibo city Boshan District Emei Road No. 56 building 3, unit 3, Room 502 Applicant before: Li Qingzhi |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20161005 Termination date: 20170424 |